PROFILPELAJAR.COM

TL 2636

TL 2636
Identifiers
  • α-Cyclohexyl-4,5α-epoxy-3-hydroxy-6-methoxy-α,17-dimethyl-6,14-ethenomorphinan-7-methanol
CAS Number
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC28H37NO4
Molar mass451.607 g·mol−1
3D model (JSmol)
  • CC([C@H]1CC23C=C[C@]1([C@H]4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)C)OC)(C7CCCCC7)O
  • InChI=1S/C28H37NO4/c1-25(31,18-7-5-4-6-8-18)20-16-26-11-12-28(20,32-3)24-27(26)13-14-29(2)21(26)15-17-9-10-19(30)23(33-24)22(17)27/h9-12,18,20-21,24,30-31H,4-8,13-16H2,1-3H3/t20-,21-,24-,25?,26?,27+,28+/m1/s1
  • Key:SHOLSAOUSMCLOR-HGRVVPQMSA-N

TL 2636 (M-125) is an opioid drug derived from thebaine, one of the bridged oripavine family of drugs known as the Bentley compounds which includes drugs such as buprenorphine and etorphine. TL 2636 is closely related to etorphine and is a similarly potent opioid analgesic and sedative, but at low doses is characterised by producing pronounced nausea and vomiting, with a long duration of action. It was investigated as a potential incapacitating agent but was not successful due to a poor therapeutic index.[1][2][3][4][5]

See also

References

  1. ^ Bentley KW, Hardy DG (June 1967). "Novel analgesics and molecular rearrangements in the morphine-thebaine group. 3. Alcohols of the 6,14-endo-ethenotetrahydrooripavine series and derived analogs of N-allylnormorphine and -norcodeine". Journal of the American Chemical Society. 89 (13): 3281–3292. Bibcode:1967JAChS..89.3281B. doi:10.1021/ja00989a032. PMID 6042764.
  2. ^ Callaway S, Hollyhock WM, Ladell WS (1963). An Oripavine Derivative (TL2636) as a Potential Incapacitating Agent. Porton Technical Paper (Report). 835, PRO/WO189/357.
  3. ^ Dando M (January 2006). The UK's Search for an Incapacitating ('Non-Lethal') Chemical Agent in the 1960s. Bradford Project on Strengthening the Biological and Toxin Weapons Convention (BTWC) (Report). University of Bradford.
  4. ^ Pearson A (2006). "Incapacitating Biochemical Weapons". The Nonproliferation Review. 13 (2): 151–188. doi:10.1080/10736700601012029.
  5. ^ Schmidt U (August 2019). "Creating a 'Father Confessor': the origins of research ethics committees in UK military medical research, 1950-1970. Part I, context and causes". Journal of the Royal Army Medical Corps. 165 (4): 284–290. doi:10.1136/jramc-2019-001206. PMID 31164389.
Stub icon

This pharmacology-related article is a stub. You can help Wikipedia by adding missing information.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.